Scientists begin Stem Cell research to find cure for Alzheimer’s
Alzheimer’s disease, the commonest cause of premature senility, is a progressive mental deterioration that occurs in middle or old age due to generalized degeneration of the brain. So far, it has been frustratingly elusive for the scientists to find a drug to slow the onset of Alzheimer’s, a major reason being that animal testing, where most research begins, doesn’t often produce results that predict very well what will happen to people with the disease.
Now, some Alzheimer’s disease scientists have taken to stem cell research and they are hopeful that the novel technique would enable more efficient testing of experimental drugs in the lab rather than in clinical trials with people. Moreover, clinical trials of drugs in humans are a quite costly and time consuming.
Scientists at the University of California, San Diego, used stem cells, which can differentiate into a number of specialized cell types, to create neurons with characteristics of Alzheimer’s.
Susan Solomon, chief executive of the nonprofit New York Stem Cell Foundation, which funds and conducts research involving stem cells, says, “Stem cells give you a window into a living human being’s brain, and that’s really extraordinary”.
According to a report from the hillaryclinton, Alzheimer’s is also one of the costliest diseases in America: Its annual cost, combined with those of related dementias, exceeds $200 billion. Recent reports suggest that by 2050 the total cost may exceed $1 trillion per year. In its human and financial costs, Alzheimer’s stands out—yet the fight against Alzheimer’s and other dementias is underfunded relative to these tremendous costs. Hillary Clinton believes that it is time for dramatic action to find a solution.
A neurologist at the Indiana University Health Neuroscience Center says Hoosiers could benefit from Democratic presidential candidate Hillary Clinton’s proposal to find a cure for Alzheimer’s disease by 2025. Dr. Liana Apostolova says increased funding and awareness could help Indiana patients and their families, told the WBAA.
The Healio notes that, Shelly L. Gray, PharmD, MS, of the University of Washington School of Pharmacy, and colleagues conducted a population-based prospective cohort study on participants from the Adult Changes in Thought study. Study participants (median age at enrollment, 74.4 years) were randomly sampled Seattle-area Group Health members recruited from 1994 to 1996. Additional participants were enrolled from 2000 to 2003
The overall ‘asthma epidemic’ among children has...Read More
People in huge numbers gathered in the Mount Lofty...Read More
As New Year is approaching, people have already...Read More
Alzheimer’s disease, the commonest cause of...Read More
Cases of opioid abuse have been increasing and...Read More
In an announcement made on December 22, cable giant...Read More